(2023)
Functional analysis of the Candida albicans ECE1 Promoter.
Microbiol Spectr ,
e0025323.

Oliver Kurzai
National Reference Center for Invasive Fungal Infections · Head Fungal Septomics · Head +49 3641 532-1347 oliver.kurzai@leibniz-hki.deCurriculum vitae
Main Research Areas
- Infection biology of human pathogenic fungi (especially Candida albicans)
- Infection biology of Neisseria meningitidis
Professional Career
Since 2017 | Chair of Medical Microbiology and Mycology, Institute for Hygiene and Microbiology, Julius Maximilians University Würzburg and head of the research group Fungal Septomics at Leibniz Institute for Natural Product Research and Infection Biology – Hans-Knöll-Institute Jena |
2009-2016 | Professor (W2) for Fungal Septomics, Friedrich-Schiller-University Jena |
2008 | Habilitation in medical microbiology, University Würzburg |
2006 | Medical specialist in microbiology, virology and infection epidemiology (Bayerische Landesärztekammer) |
2003 | Head of a working group, Institut für Hygiene und Mikrobiologie, University Würzburg |
2001-2002 | Doctor in practical training (AiP), Institut für Hygiene und Mikrobiologie, University Würzburg |
2002 | Dr. med., “summa cum laude” University Würzburg |
2001 | Staatsexamen (state examination) in human medicine, University Würzburg |
Awards · Appointments · Scientific Activities
Since 2014 | Head of the Nationales Referenzzentrums für invasive Pilzinfektionen (NRZMyk) |
Since 2013 | Board member of the Integriertes Forschungs- und Behandlungszentrum “Center for Sepsis Control and Care” (CSCC) at the University Hospital Jena |
Since 2012 | Scientific Manager of the consortium “InfectControl 2020 – New Antiinfection Strategies – Science • Society • Economy” within the BMBF-Programme “Zwanzig 20 – Partnership for Innovation” (Head: Prof. A. Brakhage) |
Since 2012 | Editor-in-chief, Medical Mycology Case Reports, member (ex officio) of the executive board of the International Society for Human & Animal Mycology (ISHAM) |
Since 2011 | Elected note taker at the Deutschsprachige Mykologische Gesellschaft DMykG |
2015-2016 | Speaker of the ZIK Septomics |
2011-2013 | Editor, Journal of Basic Microbiology |
2009 | Hans-Rieth-poster prize from the Deutschsprachige Mykologische Gesellschaft (DMykG) |
2008 | Award from the Deutsche Gesellschaft für Hygiene und Mikrobiologie |
2003 | Science award from the Unterfränkische Gedenkjahrstiftung |
2003 | Dissertation award from the medical faculty of the University Würzburg |
2002 | Becton-Dickinson PhD award from the Deutsche Gesellschaft für Hygiene und Mikrobiologie |
Publications
(2023)
Pathogen-specific innate immune response patterns are distinctly affected by genetic diversity.
Nat Commun 14(1),
3239.
(2023)
Clinical accuracy of SARS-CoV-2 rapid antigen testing in screening children and adolescents.
J Infect 86(3),
256-308.
(2023)
Obituary Prof. Ulrich Vogel, MD 1964-2022: a scientific mentor and expert in infection prevention and control.
Med Microbiol Immunol 212(1),
1-2.
(Review)
(2023)
A mould in the fold should never grow old: cutaneous aspergillosis in a preterm neonate.
Clin Microbiol Infect 29(3),
338-339.
(2023)
Influencing factors of anti-SARS-CoV-2-spike-IgG antibody titers in healthcare workers: A cross-section study.
J Med Virol 95(1),
e28300.
(2023)
Virus variant-specific clinical performance of SARS coronavirus two rapid antigen tests in point-of-care use, from November 2020 to January 2022.
Clin Microbiol Infect 29(2),
225-232.
(2023)
Immunogenicity and safety of coadministration of COVID-19 and influenza vaccination.
Eur Respir J 61(1),
2201390.
(2023)
Bivalent BNT162b2 mRNA original/omicron BA.4-5 booster vaccination: adverse reactions and inability to work compared with the monovalent COVID-19 booster.
Clin Microbiol Infect 29(4),
554-556.
(2023)
The relationship between mental health, sleep quality and the immunogenicity of COVID-19 vaccinations.
J Sleep Res ,
e13929.